Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引:0
|
作者
Markus Luster
Martin Schlumberger
Furio Pacini
机构
[1] University of Ulm,Department of Nuclear Medicine
[2] Institut Gustave Rousy,Department of Nuclear Medicine and Endocrine Oncology
[3] University of Siena,Department of Internal Medicine, Section of Endocrinology & Metabolism
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2009年 / 36卷
关键词
Thyroid Cancer; Hypothyroidism; Thyroglobulin; Differentiate Thyroid Cancer; Serum Thyroglobulin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:329 / 330
页数:1
相关论文
共 50 条
  • [31] Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant
    M. Giusti
    S. Valenti
    B. Guazzini
    E. Molinari
    D. Cavallero
    C. Augeri
    F. Minuto
    Journal of Endocrinological Investigation, 2003, 26 : 1192 - 1197
  • [32] Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant
    Giusti, M
    Valenti, S
    Guazzini, B
    Molinari, E
    Cavallero, D
    Augeri, C
    Minuto, F
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (12) : 1192 - 1197
  • [33] Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients
    Yavuz, Dilek Gogas
    Yazan, Ceyda D.
    Hekimsoy, Zeliha
    Aydin, Kadriye
    Gokkaya, Naile
    Ersoy, Canan
    Akalin, Aysen
    Topaloglu, Omercan
    Aydogan, Berna I.
    Dilekci, Esra N. A.
    Alphan Uc, Ziynet
    Cansu, Guven B.
    Ozsari, Levent
    Iyidir, Ozlem T.
    Olgun, Mehtap E.
    Keskin, Lezzan
    Mert, Meral
    Can, Bulent
    Gungor, Kaan
    Galip, Tayfun
    Canturk, Zeynep
    Elbuken, Gulsah
    Pekkolay, Zafer
    Kutbay, Nilufer O.
    Yorulmaz, Goknur
    Kalkan, Ahmet T.
    Unsal, Yasemin A.
    Yay, Adnan
    Karagun, Baris
    Bozkur, Evin
    CLINICAL ENDOCRINOLOGY, 2022, 97 (06) : 833 - 840
  • [34] Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments
    G. Grani
    D. Tumino
    V. Ramundo
    L. Ciotti
    C. Lomonaco
    M. Armillotta
    R. Falcone
    P. Lucia
    M. Maranghi
    S. Filetti
    C. Durante
    Journal of Endocrinological Investigation, 2019, 42 : 1485 - 1490
  • [35] Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution
    Wong, R.
    Topliss, D. J.
    Bach, L. A.
    Hamblin, P. S.
    Kalff, V.
    Long, F.
    Stockigt, J. R.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (03) : 156 - 163
  • [36] Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments
    Grani, G.
    Tumino, D.
    Ramundo, V
    Ciotti, L.
    Lomonaco, C.
    Armillotta, M.
    Falcone, R.
    Lucia, P.
    Maranghi, M.
    Filetti, S.
    Durante, C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (12) : 1485 - 1490
  • [37] Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis
    Fu, H.
    Ma, C.
    Tang, L.
    Wu, F.
    Liu, B.
    Wang, H.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (01) : 121 - 128
  • [38] Radioactive iodine in differentiated thyroid cancer: a national database perspective
    Orosco, Ryan K.
    Hussain, Timon
    Noel, Julia E.
    Chang, David C.
    Dosiou, Chrysoula
    Mittra, Erik
    Divi, Vasu
    Orloff, Lisa A.
    ENDOCRINE-RELATED CANCER, 2019, 26 (10) : 795 - 802
  • [39] A meta-analysis of the value of serum TSH concentration in the diagnosis of differentiated thyroid cancer in patients with thyroid nodules
    Fan, Xiao-Yu
    You, Wei
    Chen, Yao
    Nie, Chen-Cong
    Wang, Xue-Lian
    Lei, Cheng
    Song, Juan
    Luo, Huai-Li
    HELIYON, 2024, 10 (02)
  • [40] Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management
    Chen, Ming-Kai
    Doddamane, Indukala
    Cheng, David W.
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (01) : 6 - 10